Published Studies
Nicotinamide Riboside Prevents Diabetic Cardiomyopathy: Preclinical Findings
Synopsis In a mouse model of diabetic cardiomyopathy (DCM) induced by STZ and a high-fat diet, nicotinamide riboside (NR) (400 mg/kg/day) lowered fasting glucose and insulin levels, improved diast...
Read moreNicotinamide Riboside Prevents Oocyte Quality Loss in Maternal Diabetes: Preclinical Findings
Synopsis Diabetes reduces NAD+ levels in ovaries and oocytes, leading to poor oocyte quality, abnormal spindle formation, excess ROS, and impaired embryo development. In streptozotocin-induced dia...
Read moreNicotinamide Riboside Restores Lipid Handling in Diabetic Heart Disease: Preclinical Findings
Synopsis Excessive lipid droplet buildup and lipotoxicity contribute to diabetic cardiomyopathy (DCM). This study found that lipophagy—the autophagic breakdown of lipid droplets—is impaired in DCM...
Read moreNicotinamide Riboside Mitigates Diabetes-Related Bone Loss: Preclinical Findings
Synopsis Type 2 diabetes mellitus (T2DM) caused by high-fat diet/streptozotocin treatment led to impaired bone microarchitecture and bone loss in mice, along with metabolic dysfunction. Supplement...
Read moreNicotinamide Riboside and Resveratrol Enhance Wound Healing in Diabetic Rats: Preclinical Findings
Synopsis Diabetes impairs wound healing by disrupting autophagy and promoting apoptosis. In a type 1 diabetic rat model, systemic and topical nicotinamide riboside (NR) and resveratrol (RSV) signi...
Read moreNicotinamide Riboside and Resveratrol Promote Diabetic Wound Healing: Preclinical Findings
Synopsis Diabetic skin ulcers are difficult to treat and often lead to severe complications like infection or amputation. This study investigated how nicotinamide riboside (NR)—a vitamin B3–derive...
Read moreSynopsisReduced NAD+ signaling contributes to nerve degeneration in diabetic peripheral neuropathy. Researchers tested NAD+ precursors, nicotinamide riboside and nicotinamide mononucleotide, in cul...
Read moreNicotinamide Riboside Protects Against Diabetic Kidney Disease: Preclinical Findings
SynopsisDiabetic kidney disease (DKD) is a leading cause of kidney failure, linked to inflammation and mitochondrial dysfunction. This study evaluated whether boosting NAD+ metabolism via nicotinam...
Read moreSynopsisHigh-fat diet-induced insulin resistance (IR) in skeletal muscle is linked to mitochondrial dysfunction and oxidative stress. This study assessed whether nicotinamide riboside (NR) could re...
Read moreSynopsisDiabetes causes systemic oxidative stress that often leads to nerve damage in the enteric nervous system, impairing gut motility and causing symptoms such as constipation or diarrhea. Using...
Read moreSynopsisDisturbances in NAD+ metabolism have been linked to many age-related and metabolic diseases like type 2 diabetes. Pancreatic β-cells play a key role in controlling blood sugar, but how NAD+...
Read moreSynopsisDiabetic peripheral neuropathy involves nerve degeneration linked to low NAD+ levels. Researchers tested whether NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside ...
Read moreSynopsis In diabetes, heart damage often occurs because of mitochondrial imbalance, where the cell’s energy-producing structures become fragmented and dysfunctional. This study found that nicotina...
Read moreNicotinamide Riboside Improves Wound Healing in Diabetes: Preclinical Findings
Synopsis Poor wound healing is a common complication of diabetes, largely due to impaired blood vessel formation. This study found that nicotinamide riboside (NR), a vitamin B3 derivative and NAD+...
Read moreSynopsis Nicotinamide adenine dinucleotide (NAD+) is a vital molecule that supports energy metabolism, cell repair, and tissue regeneration. In diabetes, chronically high blood sugar disrupts thes...
Read moreSynopsis This study tested whether nicotinamide riboside (NR) can reduce brain inflammation and improve cognitive function in diabetic mice. Mice with diet- and chemically-induced diabetes were gi...
Read moreNicotinamide Riboside Protects Against Diabetes and Neuropathy: Preclinical Findings
SynopsisMale C57BL/6J mice fed a high-fat diet (HFD) develop prediabetes with insulin resistance and sensory neuropathy. When given low doses of streptozotocin, these mice model type 2 diabetes (T2...
Read moreNicotinamide Riboside Reduces Liver Inflammation in Diabetes: Preclinical Findings
Synopsis Chronic low-grade inflammation—known as metaflammation—is a key driver of conditions like type 2 diabetes, obesity, and cardiovascular disease. This study investigated whether nicotinamid...
Read more